Symp VId Use of Ultrasound in Preclinical Hemodynamic and Safety Assessment of Investigational Drugs

被引：0
|
作者：
DeFelice, Albert [1 ]
机构：
[1] US FDA, Off Drug Evaluat 1, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA
来源：
INTERNATIONAL JOURNAL OF TOXICOLOGY | 2011年 / 30卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 38 条
  • [11] Blood Cytokines as Biomarkers of In Vivo Toxicity in Preclinical Safety Assessment: Considerations for Their Use
    Tarrant, Jacqueline M.
    TOXICOLOGICAL SCIENCES, 2010, 117 (01) : 4 - 16
  • [12] Modelling and Simulation for Preclinical Cardiac Safety Assessment of Drugs with Human iPSC-Derived Cardiomyocytes
    Kügler P.
    Jahresbericht der Deutschen Mathematiker-Vereinigung, 2020, 122 (4) : 209 - 257
  • [13] The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey
    Colleton, Curtis
    Brewster, David
    Chester, Anne
    Clarke, David O.
    Heining, Peter
    Olaharski, Andrew
    Graziano, Michael
    TOXICOLOGIC PATHOLOGY, 2016, 44 (03) : 458 - 466
  • [14] Technological Advances in Cardiovascular Safety Assessment Decrease Preclinical Animal Use and Improve Clinical Relevance
    Berridge, Brian R.
    Schultze, A. Eric
    Heyen, Jon R.
    Searfoss, George H.
    Sarazan, R. Dustan
    ILAR JOURNAL, 2016, 57 (02) : 120 - 132
  • [15] Establishing the "Normal" Immune Response in Cynomolgus Monkey and Rat for Use in Preclinical Immunotoxicology Safety Assessment
    Faraahi, Z. F.
    Munday, J.
    Hunjan, K.
    Shaw, A.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2021, 40 (01) : 69 - 69
  • [16] Guidance on the Use of Alternative Test Methods for the Safety Assessment of Cosmetics and Quasi-drugs
    Kojima, Hajime
    Ikarashi, Yoshiaki
    Nakada, Tokio
    Yagami, Akiko
    Sugibayashis, Kenji
    Todos, Hiroaki
    Hoshino, Yukiko
    Iizuka, Naofumi
    Nakamura, Takatoshi
    Sekizawa, Shinichi
    Shinoda, Kazutoshi
    Yagi, Mio
    Araki, Daisuke
    Sakaguchi, Hitoshi
    Sasa, Hitoshi
    Sugiyama, Mariko
    ALTERNATIVES TO ANIMAL TESTING, 2019, : 63 - 68
  • [17] Serious adverse drug events related to non-investigational drugs in academic clinical trials: another source of safety data for risk assessment?
    Olivier, Pascale
    Gimbert, Anne
    Colin, Anne-Laurene
    Salvo, Francesco
    Becker, Madlyne
    Marty, Valerie
    Montastruc, Jean-Louis
    Petitpain, Nadine
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (04) : 1069 - 1075
  • [18] ASSESSMENT OF HEMODYNAMIC CEREBRAL LATERALIZATION DURING THE PERFORMANCE OF VERBAL MNESTIC TASKS WITH THE USE OF FUNCTIONAL TRANSCRANIAL DOPPLER ULTRASOUND
    Mikadze, Yu. V.
    Bogdanova, M. D.
    Lysenko, E. S.
    Shakhnovich, A. R.
    Abuzaid, S. M.
    EKSPERIMENTALNAYA PSIKHOLOGIYA, 2015, 8 (03): : 62 - 73
  • [19] Preoperative Hemodynamic Assessment with Point of Care Transthoracic Ultrasound: Feasibility of Routine Use and Effects on Operating Room Efficiency
    Louro, Jack
    Rowshanrad, Amir
    Cobas, Miguel
    Dudaryk, Roman
    ANESTHESIA AND ANALGESIA, 2017, 124 : 1013 - 1014
  • [20] Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval
    Borer, Jeffrey S.
    Pouleur, Hubert
    Abadie, Eric
    Follath, Ferrenc
    Wittes, Janet
    Pfeffer, Marc A.
    Pitt, Bertram
    Zannad, Faiez
    EUROPEAN HEART JOURNAL, 2007, 28 (15) : 1904 - 1909
1234